News
Vamousse™ head lice treatment available at over 4,000 Walmart stores in the USA
1 April 2014
Further to its 14 January 2014 announcement, TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focusing on nature-derived insect and parasite control products, is pleased to confirm its breakthrough head lice treatment product, Vamousse™, is now available in more than 4,000 Walmart stores in the USA.
Bruno Jactel, Chief Executive Officer, said: "The Board is very pleased that we are currently on schedule both in terms of number of stores and timings of sales for our Vamousse™ head lice treatment, with products already selling in the USA. We are confident this roll-out will greatly raise the profile of Vamousse™."
Further information on Vamousse™ is available on the Company's website at: www.tyratech.com/content/company-products/head-lice.asp
For further information please contact:
| TyraTech Inc. Alan Reade, Non-Executive Chairman Bruno Jactel, Chief Executive Officer |
Tel: +44 7841978709 Tel: +1 919 415 4340 |
| SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady |
Tel: +44203 368 3551 |
| Allenby Capital Limited , Joint Broker Chris Crawford |
Tel: +44 20 3328 5656 |
| Whitman Howard Limited, Joint Broker Ranald Mc-Gregor Smith / Niall Devins |
Tel: +44 20 7087 4555 |
| Walbrook, Financial PR and IR Bob Huxford /Guy McDougall (Public Relations) Paul Cornelius (Investor Relations) |
Tel: +44 20 7933 8792 Tel: +44 20 7933 8794 |
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.